Decision: Unfavourable
Study Title:
CONNected Electronic Inhalers Asthma Control Trial 3 (“CONNECT 3”), a 24-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison Study of Standard of Care Treatment Versus the Budesonide/Formoterol Digihaler Digital System, to Optimize Outcomes in Adult Patients with Asthma
NREC Code:
22-NREC-CT-028
Decision:
Unfavourable
Study Type:
CT application
Principal Investigator:
Dr Richard Costello
PI Institution:
Beaumont Hospital
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.